æ¬æ¥
+0.22%
5æ¥é
-0.21%
1ã¶æ
+0.26%
6ã¶æ
+42.56%
å¹Žåæ¥
+23.43%
1幎é
+41.81%
⢠éçºäžã®æ²»çè¬ã«ãããèšåºè©Šéšã®å€±æãèŠå¶åœå±ã«ããæ¿èªæç¶ãã®é ãããAstraZenecaã®æ ªäŸ¡ã«äžæŒãå§åããããŠããŸãã â¢ æ¯æ°ææã»ã¯ã¿ãŒãžã®å¹ åºãåžå Žè³éã®ã·ããïŒããŒããŒã·ã§ã³ïŒã«ããããã£ãã§ã³ã·ããªè£œè¬æ ªããè³éãæµåºããŠããŸãã ⢠åµè¬åãã®æ°èAIãã©ãããã©ãŒã ã®å°é ã«ãããæè³å®¶ã¯åŸæ¥ã®è£œè¬äŒæ¥ã®ããªã¥ãšãŒã·ã§ã³ïŒäŒæ¥äŸ¡å€è©äŸ¡ïŒãåè©äŸ¡ããåããèŠããŠããŸãã
⢠米é£åå»è¬åå±ïŒFDAïŒã¯ãé²è¡ããªãã«ãã¬ãã£ãä¹³ããã®æ²»çã«ãããŠKeytrudaããã³Trodelvyãæ¿èªããã ⢠FDAã¯ãå°å çšèºççèã¯ã¯ãã³ãCapvaxiveãã®é©å¿æ¡å€§ãæ¿èªããã ⢠çµå¶é£ã¯ã2026幎ã®å£²äžé«ããã³1æ ªåœããå©çïŒEPSïŒã®æ¥çžŸäºæ³ïŒã¬ã€ãã³ã¹ïŒãåŒãäžããã
⢠ã¢ããŽã£ã¯ãApogee TherapeuticsãçŸéçŽ109åãã«ã§è²·åããããšã«åæããã ⢠欧å·å§å¡äŒã¯ãäžççããéçã®å°åžžæ§ä¹Ÿç¬ã®å°å æ£è ã察象ã«Skyriziãæ¿èªããã ⢠ã¢ããŽã£ã¯ãæ ªäž»ã«å¯ŸããŠ1æ ªåœãã1.73ãã«ã®ååæçŸéé åœãçºè¡šããã


| æ ªäž»çµ±èš | æ¯ç |
|---|---|
| Vanguard Capital Management, LLC | 6.50% |
| BlackRock Institutional Trust Company, N.A. | 5.84% |
| Vanguard Portfolio Management, LLC | 4.14% |
| State Street Investment Management (US) | 3.71% |
| çš®é¡ | æ¯ç |
|---|---|
| Investment Advisor | 60.06% |
| Investment Advisor/Hedge Fund | 37.12% |
| Hedge Fund | 9.13% |
| Research Firm | 2.58% |
é¢é£éèåå